ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
GlaxoSmithKline plans to close an R&D site employing 70 people just outside of Paris. The move is part of an effort the firm revealed last year to save $1.6 billion by consolidating most R&D operations to sites in Stevenage, England, and Philadelphia. GSK says it will look for a pharmaceutical buyer for the site near Paris in an effort to preserve jobs. Despite the R&D cutback, GSK says it plans to bolster French employment through 2016 by about 300 jobs at the three manufacturing sites it operates in the country.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter